extracellular exosome

Overview

Extracellular exosomes are small extracellular vesicles released by cells into the extracellular space and found in many body fluids, including human plasma, urine, and nipple discharge. They carry membrane proteins, lipids, and nucleic acids that reflect the molecular state of their parent cells, making them important mediators of intercellular communication and attractive candidates for biomarker discovery, drug delivery, and therapeutic engineering. In biomedical research, exosomes are often discussed together with broader extracellular vesicle populations, but the term specifically refers to a nanoscale vesicular subtype with a defined biogenesis pathway.

From a therapeutic and translational perspective, exosomes are being investigated both as natural delivery vehicles and as disease-associated analytes. Their membrane composition and cargo can be exploited for targeted delivery of drugs, nucleic acids, or genome-editing systems, while their endogenous origin may offer advantages over synthetic carriers. At the same time, their abundance and molecular signatures are being studied for noninvasive sensing strategies in cancer and other diseases, including breast cancer, bladder cancer, and neurological and inflammatory disorders.

Recent Publications Summary

Recent studies used extracellular exosomes as both therapeutic vehicles and disease biomarkers across cancer, cardiovascular disease, infection, and inflammatory models. In a TMUV infection model, exosomes derived from infected cells carried viral genomic RNA and multiple viral proteins, entered HEK293 cells through dynamin-dependent, cholesterol-sensitive caveolae-mediated endocytosis, and promoted productive infection by suppressing antiviral immune gene expression; this process was linked to an NS4A–Rab27a regulatory axis that enhanced exosome release 42572027Aug. In cardiac injury, M2 macrophage-derived exosomes containing miR-124 attenuated Ang II-induced hypertrophy and fibrosis in mice and reduced fibrotic and hypertrophic responses in cardiac cells, with Calpain-1 identified as a key downstream target 42102612May. In Sandhoff disease, inflammatory-primed stromal cell extracellular vesicles reduced in vitro neuroinflammation and lowered IL-6, TNF-α, and IL-1β in neuronal-mixed glia 42436308Jul. In rheumatoid arthritis, USP21-enriched mesenchymal stem cell-derived exosomes alleviated synovial hyperplasia, oxidative stress, and joint damage in a collagen-induced arthritis model by restoring autophagy balance in fibroblast-like synoviocytes 42302977Jun.

Several publications focused on exosome characterization and liquid biopsy applications. A smartphone-based fluorescence biosensing platform detected CD63-positive exosomes with a CD63-specific aptamer capture step and a tumor-specific fluorescent aptamer, achieving detection within 45 minutes and a reported limit of detection of 4.58 × 10^6 particles/ml 42520835Jul. A peptide-based fluorescent probe platform was developed for HER2-positive exosomes, using optimized HER2-binding peptides and multivariate fluorescence analysis to distinguish HER2-enriched exosomes in cell-derived samples, plasma, and urine 42215863May. In bladder cancer, a herringbone microfluidic system with photonic crystal-encoded hydrogel microcarriers enabled exosome enrichment and multiplexed profiling of six proteomic biomarkers from urinary exosomes, supporting high-throughput early detection and monitoring 41740420Feb. Exosomal microRNA analysis was also explored in nipple discharge for breast cancer screening, with cellulose nanofiber sheets proposed to facilitate biomarker identification from low-volume samples 42307695Jun.

Other studies examined how exosome properties vary with physiological state and tissue source. In healthy dogs, aging was associated with lower plasma exosome yield and altered size characteristics, alongside differences in molecular cargo including selected miRNAs 42319614Jun. In postoperative intra-abdominal adhesion, mesenchymal stem cell-derived exosomes from umbilical cord and adipose tissue were compared in a rat model, with treatment groups assessed for adhesion severity, fibrosis, inflammation, neovascularization, and markers such as collagen I, FGF2, VEGF, and HIF-1α 41997426Apr. In breast cancer cell models, menstrual blood stem cell-derived exosomes reduced cell survival, migration, and angiogenesis-related behavior in MDA-MB-231 and SK-BR-3 cells, with associated changes in apoptosis, ROS generation, and expression of BAX, BCL-2, MMP-2, and VEGF 42159846May. Reviews of diabetic kidney disease also highlighted mesenchymal stem cells and their derived extracellular vesicles as regenerative approaches being investigated alongside senotherapeutics 41581730Jan, while broader CRISPR-Cas12a diagnostics reviews noted exosomes among the analytes targeted by emerging biosensing technologies 41500123Jan.

What Changes, What Holds

1. Exosomes now appear to carry pathogenic viral material and can amplify infection
NEW DIRECTION Exosomes from infected cells are no longer just intercellular messengers or candidate delivery vehicles; in this model they also shuttle viral RNA and proteins into new cells and help suppress antiviral responses, while an NS4A–Rab27a axis increases their release 42572027Aug. That adds a disease-propagating role not covered by the baseline and tempers any blanket therapeutic optimism. The host-derived cardiac, neuroinflammatory, and arthritis studies still fit the broader therapeutic use of exosomes 42102612May42436308Jul.

2. Exosome analysis is moving toward faster, more selective liquid-biopsy workflows
METHOD Smartphone fluorescence readout, peptide-targeted probes, microfluidic enrichment, and low-volume nipple-discharge processing change how exosomes are captured and profiled rather than what exosomes are understood to do 42520835Jul42215863May. The baseline already frames them as biomarker candidates, and these studies mainly sharpen that translational promise by making detection more practical, multiplexed, and sample-sparing. The underlying biomarker concept is reinforced, but the new contribution is methodological rather than conceptual.

3. Exosome properties are increasingly treated as state-dependent and source-dependent
REINFORCES Aging-related shifts in plasma yield and cargo, comparisons across mesenchymal stem cell sources, and context-specific anti-inflammatory or anti-tumor effects all support the baseline view that exosome composition reflects the parent cell and physiological state 42319614Jun41997426Apr. Rather than changing what exosomes are for, this work sharpens the importance of source, age, and disease context when interpreting them as analytes or therapeutics. It also argues against treating all exosome preparations as interchangeable.

Overview update candidates: infection-enhancing exosomal viral cargo; state- and source-dependence of exosome yield and cargo.